Feature Channels:

Drug Resistance

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Finding the Perfect Match: A New Approach to Battle Drug-Resistant Bacteria

Antibiotics were the wonder drug of the 20th century, but bacteria evolved resistance. According to the CDC, more than 2 million people in the U.S. develop MDR infections every year. Researchers at Univ. of Utah developed a rapid screen to pair existing FDA-approved drugs to combat MDR infections.

Medicine

Channels:

Microbiome, Antibiotics, antiseptics

Penn Study Details Impact of Antibiotics, Antiseptics on Skin Microbiomes

GriceGramStain.jpg

The use of topical antibiotics can dramatically alter communities of bacteria that live on the skin, while the use of antiseptics has a much smaller, less durable impact. The study, conducted in mice in the laboratory of Elizabeth Grice, PhD, an assistant professor of Dermatology in the Perelman School of Medicine at the University of Pennsylvania, is the first to show the long-term effects of antimicrobial drugs on the skin microbiome.

Medicine

Channels:

Teaching Transgender Respect, Methamphetamine Use Disorder Trial, Rx Drug Cost, and More in the Healthcare News Source

The latest research, features and announcements in healthcare in the Healthcare News Source

Medicine

Channels:

UTI, Urinary Tract Infection , E. Coli, Mannose

UTI Treatment Reduces Gut E. Coli, May Offer Alternative to Antibiotics

UPEC-Image-1_forweb.jpg

Most UTIs are caused by E. coli that live in the gut and spread to the urinary tract. A new study from Washington University School of Medicine in St. Louis has found that a molecular decoy can reduce the numbers of UTI-causing bacteria in the gut, potentially reducing the risk of recurrent UTI.

Medicine

Channels:

GW School of Medicine and Health Sciences, Global Health, Parisitology, Tropical Medicine, Immunology, Vaccine Development, Drug Resistance, Hookworm, hookworm vaccine

GW Receives $3 Million Grant to Test Hookworm Vaccine Efficacy in Phase II Clinical Trial

GW Researchers received a $3 million U01 grant from the National Institutes of Health to test the efficacy of a candidate recombinant hookworm vaccine, the next step in their goal to fight hookworm.

Business

Channels:

UMB, Serenta License Agreement Welcomed in Quest To Combat Deadly Antibiotic-Resistant Staph Infections

mark_1.jpg

UMB grants licensing rights for new vaccine candidate to Serenta Biotechnology, LLC, whose co-founder, Mark Shirtliff, PhD, professor at the University of Maryland School of Dentistry and the UM School of Medicine.

Medicine

Science

Channels:

MRSA, Infection, Health, Medicine, Disease

New Antibiotic Packs a Punch Against Bacterial Resistance

PNAS_Paper_Summary_5_23_17.jpg

Scientists at The Scripps Research Institute (TSRI) have given new superpowers to a lifesaving antibiotic called vancomycin, an advance that could eliminate the threat of antibiotic-resistant infections for years to come.

Medicine

Channels:

University At Buffalo, Superbug, Hospital Infection, Pharmacy

Ineffective Antibiotics Form Strong Teams Against Deadly Super Bacteria

A team of researchers found that combinations of three antibiotics – that are each ineffective against superbugs when used alone – are capable of eradicating two of the six ESKAPE pathogens when delivered together.

Medicine

Channels:

Antibiotics, Antibiotic Resistance, Bacteria, antibacterial resistance, Metals, organic acids, Food Pathogens, Food Preservation, Agricultural Chemicals And Pathogens, Israel, Innovation

A Possible Alternative to Antibiotics

Technion researchers say a combination of metals and organic acids is an effective way to eradicate cholera, salmonella, pseudomonas, and other pathogenic bacteria. The combination also works on bacteria that attack agricultural crops.

Medicine

Channels:

New Bladder Cancer Drug, Skin Cancer Facts, Advanced Stage Colorectal Cancer, and More in the Cancer News Source

Click here to go directly to the Cancer News Source







Chat now!